2011 Publications

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RSE, Perkins DO, McEvoy J, Stroup TS, Vann RE, Beardsley PB, Lieberman JA, Sullivan PF, van den Oord EJ.

Neuropsychopharmacology  36 (3): 616-626.

Genome-wide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Adkins DE, Aberg K, McClay JL, Bukszár J, Zhao Z, Jia P, Stroup TS, Perkins D, McEvoy JP, Lieberman JA, Sullivan PF, van den Oord EJ.

Molecular Psychiatry  16 (3): 321-332.

Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

McClay JLAdkins DE, Aberg K, Stroup S, Perkins DO, Vladimirov VI, Lieberman JA, Sullivan PF, van den Oord EJ.

Molecular Psychiatry  16 (1): 76-85.